The Effect of Outpatient Management of Cystic Fibrosis Exacerbation on Pulmonary Function Tests: A Clinical Trial

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 155

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_INJPM-10-6_001

تاریخ نمایه سازی: 11 تیر 1401

Abstract:

Background: Cystic fibrosis (CF) is an inherited disease which involves multiple organs including respiratory tract. It results in chronic respiratory signs and symptoms which exacerbate with frequent lung infections. The majority of exacerbations require hospitalization and intravenous antibiotic therapy as part of the management. The aim of this survey was to study the effectiveness of outpatient management of pulmonary exacerbations on pulmonary function tests.Methods: This randomized clinical trial included all CF patients older than ۶ years old who presented with a pulmonary exacerbation and were able to perform Spirometric tests. All eligible CF patients first referred to pulmonary function tests center to determine forced expiratory volume in the first second (FEV۱), residual volume (RV), total lung capacity (TLC) and airway specific resistance (SRaw). Then, they were treated outpatiently for ۲ to ۴ weeks and after that, they underwent all the tests again; and the participants’ improvements in pulmonary function tests after outpatient treatment were investigated.Result: In this study, ۳۲ patients were enrolled including ۱۳ women (۴۰.۶%) and ۱۹ men (۵۹.۴%). Mean and standard deviation (SD) of pulmonary variable, before and after the treatment were investigated. All of them were statistically significant. Sub-analysis of data based on gender was also performed showing that outpatient treatment led to significant improvements in all of the variables except for the percentage of RV in females (p value = ۰.۰۸).Conclusion: The findings revealed that outpatient management of CF exacerbations effectively improved values of FEV۱, SRaw and TLC along with reducing RV values and air trapping. Thus, applying this method on appropriately selected CF patients, may prevent unnecessary hospitalization and subsequent disadvantages.

Authors

Seyed Hossein Mirlohi

School of Medicine, children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Alireza Daneshbakhtiar

Pediatric department. Taleghani hospital. Abadan University of medical sciences. Abadan. Iran.

Mehrnaz Olfat

Pediatrician, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Roholla Shirzadi

Pediatric pulmonary disease and sleep medicine research Center. Pediatric Center of excellence. Children’s medical center. Tehran University of medical sciences. Tehran. Iran.

Niloufar Ghanbari

MD, Pediatrician.Emergency devision,Bahrami hospital,Tehran University of Medical Science,Tehran,Iran

Seyed Javad Sayedi

Associate Professor of Pediatric Pulmonology, Mashhad University of Medical Sciences, Mashhad, Iran.

Tina Loghmani

Mashhad University of Medical Sciences

Mohammadreza Modaresi

MD, Pediatric Pulmonologist, Pediatric pulmonary Disease and sleep Medicine Research Center, Children’s medical center Hospital, Tehran University of medical sciences, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Kliegman. Nelson textbook of pediatrics. ۱۸th ed. Philadelphia: Saunders; ۲۰۰۷ ...
  • Hassanzad M, Ansari M, Valinejadi A, Sayedi SJ, Velayati AA. ...
  • Brunson JM, Bridges D, Anderson R, Graves N, Schwann C. ...
  • Mehta A. CFTR: more than just a chloride channel. Pediatr ...
  • Sharma GD. Cystic Fibrosis (Online). ۲۰۱۲. (cited ۲۰۱۲ Apr ۳); ...
  • Denis MS, Ramotar K, Vandemheen K, Tullis E, Ferris W, ...
  • Bhatt JM۱. Treatment of pulmonary exacerbations in cystic fibrosis. Eur ...
  • Lukic KZ, Coates AL۱, ۲. Does the FEF۲۵-۷۵ or the ...
  • Horck MV, Winkens B, Wesseling G, Vliet DV, Kant KVd, ...
  • Nielsen KG, Pressler T, Klug B, Koch C, Bisgaard H. ...
  • Topalovic M, Derom E, Osadnik CR, Troosters T, Decramer M, ...
  • Pittman JE۱, Johnson RC, Davis SD. Improvement in pulmonary function ...
  • Nicholson TT, Barry PJ, Waterhouse DF, Nolan GM, McKone EF, ...
  • Godfrey S, Mearns M. Pulmonary function and response to exercise ...
  • Werkman MS, Hulzebos HJ, Arets HG, van der Net J, ...
  • Briggs EC, Nguyen T, Wall MC and MacDonald KD. Oral ...
  • نمایش کامل مراجع